News

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE VANCOUVER, B.C.: SEPTEMBER 25, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") a healthcare company with a developing research and clinical trials division announces its subsidiary EPW Curesearch LLC (“EPWC”) has been awarded its first clinical trial from a major European pharmaceutical company with a market cap over $100 Billion,...

read more

Categories